학술논문

Pomalidomide, bortezomib, and dexamethasone for patients with relapsed or refractory multiple myeloma previously treated with lenalidomide (OPTIMISMM): a randomised, open-label, phase 3 trial
Document Type
Article
Author
Abildgaard, NielsAdler, HowardAltuntas, FevziAkay, Olga MeltemAmin, BipinkumarAnagnostopoulos, AchilleasAnderson, LarryAnttila, PekkaAraujo, CarlaArce-Lara, CarlosAydin, YildizBasu, SupratikBattini, RamakrishnaBeeker, ThaddeusBenboubker, LotfiBen-Yehuda, DinaBladé, JoanBlau, Igor WolfgangBoccia, RalphBurke, LillianByeff, PeterCascavilla, NicolaCavo, MicheleChantry, AndrewCharles, YenChaudhry, ArvindCorso, AlessandroCoyne, MarkDe Arriba, FelipeDelimpasi, SosanaDesjardins, PierreDhakal, BinodDi Bartolomeo, PaoloDi Raimondo, FrancescoDürig, JanEngelhardt, MonikaEscoffre-Barbe, MartineEsteves, GracaFlogegard, MaxGabrail, NashatGamberi, BarbaraGarrison, MitchellGay, JulieGisslinger, HeinzGoldschmidt, HartmutGoncalves, CristinaGressot, LaurentGrosicki, SebastianHanna, WahidHayden, PatrickHenriques Bernardo, Maria ManuelaHermann, RobertHolden, ViranHonkalehto, KirstiHuben, MarianneHuffman, JohnHunter, HannahHus, MarekJagasia, MadanJagganath, SundarJanakiram, MuraliJaiyesimi, IshmaelJenner, MatthewJoão, CristinaJohnson, PeterJurcyszyn, ArturKalayoğlu Beşişik, SevgiKambhampati, SumanKanate, AbrahamKaradoğan, IhsanKhojasteh, AliKirkel, DeanKomarnicki, MieczyslawKrauth, Maria-TheresaKuriakose, PhillipLarocca, AlessandraLauri, BirgittaLeleu, XavierLucio, PauloLuppi, MarioMangiacavalli, SilviaMariette, ClaraMatsue, KoseiMellqvist, Ulf-HenriMendeleeva, LarisaMeshad, MichaelMiller, CaroleMohrbacher, AnnMoreau, PhilippeMorelli, Anna MariaMüldür, ErcanNaassan, AnthonyNahi, HarethNair, RajeshO'Dwyer, MikeÖngören Aydin, SenizOpenshaw, ThomasO'Rourke, TimothyOsswald, MichaelOverton, LindsayPati, AsminPavic, MichelPegourie, BrigittePehlivan, MustafaPierola, Ana AlfonsoPlesner, TorbenPluta, AndrzejRabin, NeilRamasamy, KarthikRambaldi, AlessandroRodriguez, PaulaRöllig, ChristophRosenblatt, JacalynRosenbluth, JonathanSalomo, MortenSamoylova, OlgaSastre Moral, JoseSati, HamdiSelleri, CarmineShafeek, SalimShinagawa, AtsushiSleckman, BethanySmith, ClaySonmez, MehmetStone, ChesterStreetly, MatthewSuzuki, KenshiTaetle, RaymondTafuri, AgostinoTakezako, NaokiTeke, Hava ÜsküdarVapaatalo, MirjaVassilopoulos, GeorgeVerma, AmitVidito, SarahViterbo, LuisaVural, FilizWang, Xiang SeanYağci, MunciYee, AndrewRichardson, Paul GOriol, AlbertBeksac, MeralLiberati, Anna MarinaGalli, MonicaSchjesvold, FredrikLindsay, JindriskaWeisel, KatjaWhite, DarrellFacon, ThierrySan Miguel, JesusSunami, KazutakaO'Gorman, PeterSonneveld, PieterRobak, PawelSemochkin, SergeySchey, SteveYu, XinDoerr, ThomasBensmaine, AmineBiyukov, TsvetanPeluso, TeresaZaki, MohamedAnderson, KennethDimopoulos, Meletios
Source
In The Lancet Oncology June 2019 20(6):781-794
Subject
Primary Research
Articles
Language
ISSN
1470-2045